Picture of Oramed Pharmaceuticals logo

ORMP — Oramed Pharmaceuticals News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousSmall CapSuper Stock

Brief: Oramed Reports Third Quarter 2022 Financial Results

Nov 10 (Reuters) - Oramed Pharmaceuticals Inc  ORMP.O :
    * ORAMED REPORTS THIRD QUARTER 2022 FINANCIAL RESULTS
    * ORAMED PHARMACEUTICALS INC - QTRLY LOSS PER SHARE $0.18

Source text for Eikon:  ID:nPnchHRFa 
Further company coverage:  ORMP.O 
 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Oramed Pharmaceuticals

See all news